Activities

• 

  Mary Grace N. Tamio   

  on February 04 2022 at 06:50 PM Edited public

  Trametinib represents potential new standard-of-care for patients with recurrent low-grade serous ovarian carcinoma
  
  #trametinib #ovariancarcinoma
  
  For more information | ⬇️
  https://cn1699.com/news/trametinib-represents-potential-new-standard-care-patients-recurrent-low-grade-serous-ovarian

  

  Trametinib represents potential new standard-of-care for patients with recurrent low-grade serous ovarian carcinoma | CN1699

  A study led by researchers at The University of Texas MD Anderson Cancer Center reported that the MEK inhibitor trametinib reduced the risk of...
  0 0 0 0 0 0 0

  comment Comment

  thumb_upLike

  share Share